Kevin Baumgartner, MD

Emergency Medicine Physician: Medical Toxicology, Director of Quality Improvement: Division of Medical Toxicology, Assistant Professor of Emergency Medicine



I am an Assistant Professor of Emergency Medicine in the Division of Medical Toxicology at Washington University in St. Louis School of Medicine. My clinical research focuses on the safe and effective use of sedatives and psychoactive medications in acute medical care, particularly in the emergency department (ED). My current primary focus is the use of dexmedetomidine (DEX) in the ED environment. My key publications in this area include two systematic reviews on the use of DEX, one focused on the treatment of toxicologic conditions, and one covering all uses of DEX in the ED. My research team recently completed a prospective observational cohort study of the use of DEX in the ED, which I am preparing to submit for publication. I have successfully obtained grant funding for my clinical research, including a grant from the Washington University Institute of Clinical & Translational Sciences that supported by prospective study of DEX in the ED and an ongoing grant from the Society for Academic Emergency Medicine Foundation to study the human immune response to crotalid envenomation. My editorial work as a member of the editorial board of Clinical Toxicology and my work as a reviewer for several other journals, including Critical Care Medicine, has allowed me to obtain extensive useful experience in research methods and manuscript development. I have obtained focused instruction and mentoring on clinical research through my participation in the ANTIDOTE Institute (a yearlong research course incorporating mentoring & project development, sponsored by the American College of Medical Toxicology).